The Egyptian hepatitis C programme: A model of HCV treatment intervention?

Affiliations

¹ Department of Surgery and Cancer, St Mary's Hospital, Imperial College London, UK. Electronic address: m.lemoine@imperial.ac.uk.
² Division of Infectious Diseases, St Mary's Hospital, Imperial College London, UK.

Free article

Editorial

M Lemoine et al. J Hepatol. 2018 Apr.

Free article

. 2018 Apr;68(4):638-639.

doi: 10.1016/j.jhep.2018.01.021. Epub 2018 Jan 31.

¹ Department of Surgery and Cancer, St Mary's Hospital, Imperial College London, UK. Electronic address: m.lemoine@imperial.ac.uk.
² Division of Infectious Diseases, St Mary's Hospital, Imperial College London, UK.

No abstract available

Comment on

Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience.
Elsharkawy A, El-Raziky M, El-Akel W, El-Saeed K, Eletreby R, Hassany M, El-Sayed MH, Kabil K, Ismail SA, El-Serafy M, Abdelaziz AO, Shaker MK, Yosry A, Doss W, El-Shazly Y, Esmat G, Waked I. Elsharkawy A, et al. J Hepatol. 2018 Apr;68(4):691-698. doi: 10.1016/j.jhep.2017.11.034. Epub 2017 Dec 6. J Hepatol. 2018. PMID: 29223371